Are monocytes the canary in the coal mine for HIV-related atherosclerosis?

Journal of Infectious Diseases

Volumn 206, Issue 10, 2012, Pages 1491-1493

  Crowe, Suzanne M ^a,b,c   Hoy, Jennifer F ^b,c  

^a BURNET INSTITUTE   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; C REACTIVE PROTEIN; CD11B ANTIGEN; CD14 ANTIGEN; CD163 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; LIPOPOLYSACCHARIDE; PROTEINASE INHIBITOR;

ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BACTERIAL TRANSLOCATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DISEASE COURSE; HEART INFARCTION; HEART PROTECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INNATE IMMUNITY; MONOCYTE; NOTE; PRIORITY JOURNAL; PROGNOSIS; RISK REDUCTION; VIRUS LOAD;

ANTIGENS, CD14; ATHEROSCLEROSIS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MALE;

EID: 84867709739     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis551     Document Type: Note

References (12)

1. Islam FM, Wu J, Jansson J, Wilson DP. Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis. HIV Med 2012; [Epub ahead of print].
2. Kelesidis T, Kendall MA, Yang OO, Hodis HN, Currier JS. Biomarkers of microbial translocation and macrophage activation are associated with progression of subclinical atherosclerosis in HIV-1 infection. J Infect Dis 2012; in press.
3. Ross A, Aldrovandi G, Rollie A, O'Riordan MA, Storer N, Labbato D, McComsey G. The relationship of microbial translocation and monocyte-activation markers with CVD risk in HIV+ children and young adults [abstract 976]. In: Program and abstracts of the 19th Conference on Retroviruses and Opportunistic Infections. Seattle, 2012.
4. Burdo TH, Lo J, Abbara S, et al. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J Infect Dis 2011; 204:1227-36.
5. Funderburg N, Zidar D, Shive C, et al. Inflammatory and patrolling monocyte phenotype linked to predictors of mortality in HIV-infection and the acute coronary syndrome in uninfected subjects [abstract 18H]. In: Program and abstracts of the 8th HIV, Cells of Macrophage/Dendritic Lineage and Other Reservoirs, Italy, 2012.
6. Romero-Sánchez MC, González-Serna A, Pacheco YM, et al. Different biological significance of sCD14 and LPS in HIV-infection: Importance of the immunovirology stage and association with HIV-disease progression markers. J Infect 2012; [Epub ahead of print].
7. Tseng ZH, Secemsky EA, Dowdy D, et al. Sudden cardiac death in patients with human immunodeficiency virus infection. J Am Coll Cardiol 2012; 59:1891-6.
8. Currier JS, Kendall MA, Henry WK, et al. Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults. AIDS 2007; 21:1137-45.
9. Worm SW, Sabin C, Weber R, et al. Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. J Infect Dis 2010; 201:318-30.
10. El-Sadr WM, Lundgren JD, Neaton JD, et al. CD4+ count guided interruption of antiretroviral treatment. N Engl J Med 2006; 355:2283-96.
11. Baker JV, Henry WK, Patel P, et al. Progression of carotid intima media thickness in a contemporary human immunodeficiency virus cohort. Clin Infect Dis 2011; 53: 826-53.
12. Rubin JB, Borden WB. Coronary heart disease in young adults. Curr Atheroscler Rep 2012; 14:140-9.